Non-invasive quantification of the extracellular volume (ECV) is a method for the evaluation
of focal and diffuse myocardial fibrosis, potentially obviating the need for invasive …

Background Computed tomography (CT)–derived extracellular volume fraction (ECV) is a
noninvasive method to quantify myocardial fibrosis. Although studies suggest CT is a …

Aims Transcatheter aortic valve implantation (TAVI) is the treatment of choice for high-risk
patients with severe aortic stenosis (AS). A portion of TAVI recipients has no long-term …

Aortic stenosis is a very common disease. Current guidelines recommend intervention
mainly in symptomatic patients; aortic valve replacement can be considered in asymptomatic …

Background Transcatheter aortic valve implantation (TAVI) improved outcome of patients
with severe aortic valve stenosis (AS). Myocardial fibrosis is associated with AS-related …

Background Cardiac computed tomography quantification of extracellular volume fraction
(CT-ECV) is an emerging biomarker of myocardial fibrosis which has demonstrated high …

Background Transcatheter aortic valve replacement (TAVR) has become an established
method of aortic stenosis treatment but suffers from the risk of heart block and pacemaker …

Aortic stenosis (AS) is the most frequent degenerative valvular disease in developed
countries. Its incidence has been constantly rising due to population aging. The diagnosis of …

Myocardial fibrosis (MF) is a common endpoint in most pathological mechanisms affecting
cardiac muscle occurring as focal or diffuse fibrosis. Extracellular volume (ECV) is a …

Severe aortic stenosis (AS) is often characterized by myocardial interstitial fibrosis.
Myocardial interstitial fibrosis, classically measured by magnetic resonance imaging, was …